Category «Coronavirus disease»

Sinovac COVID-19 vaccine, CoronaVac,

It’s only fair to share… Sinovac COVID-19 vaccine, CoronaVac, PiCoVacc CoronaVac, also known as the Sinovac COVID-19 vaccine,[1] is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech.[2] It has been in Phase III clinical trials in Brazil,[3] Chile,[4] Indonesia,[5] the Philippines,[6] and Turkey.[7] It relies on traditional technology similar to BBIBP-CorV and BBV152, other inactivated-virus COVID-19 vaccines in Phase III trials.[8] CoronaVac does not need to be frozen, and both the …

Sputnik V, Gam-COVID-Vac, Gamaleya

It’s only fair to share…   Sputnik V Gam-COVID-Vac Gamaleya SARS-CoV-2 Gam-COVID-Vac Lyo Gam-COVID-Vac was created by Gamaleya Research Institute of Epidemiology and MIcrobiology in Russia. The vaccine candidate is a heterologous COVID-19 vaccine containing two components, recombinant adenovirus type 26 (rAd26) vector and recombinant adenovirus type 5 (rAd5) vector which both carry the SARS-CoV-2 …

NOVAWAX, NVX-CoV2373,

It’s only fair to share… NOVAWAX NVX-CoV2373 SARS-CoV-2 rS Nanoparticle Vaccine MCDC OTA agreement number W15QKN-16-9-1002 Novavax COVID-19 vaccine, Coronavirus disease 19 infection SARS-CoV-2 rS,  TAK 019 Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it had an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal …

BBIBP-CorV, Sinopharm COVID-19 vaccine

It’s only fair to share… BBIBP-CorV, Sinopharm COVID-19 vaccine CAS Number 2503126-65-4 Inactivated novel coronavirus (2019-CoV) vaccine (Vero cells) Purified inactivated SARS-CoV-2 Vaccine ref Lancet Infectious Diseases (2021), 21(1), 39-51. BBIBP-CorV, also known as the Sinopharm COVID-19 vaccine,[1] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. In late December 2020, it was in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 …

Moderna COVID-19 vaccine, mRNA 1273

It’s only fair to share… Moderna COVID-19 vaccine, mRNA 1273 CAS 2457298-05-2 An mRNA vaccine against SARS-CoV-2 expressing the prefusion-stabilized SARS-CoV-2 spike trimer MRNA-1273 SARS-COV-2 CX 024414 CX-024414 CX024414 mRNA-1273 NAME DOSAGE STRENGTH ROUTE LABELLER MARKETING START MARKETING END Covid-19 Vaccine Moderna Injection Intramuscular Moderna Therapeutics Inc 2020-12-23 Not applicable Moderna COVID-19 Vaccine Injection, suspension 0.2 …

COVAXIN, BBV 152

It’s only fair to share… COVAXIN CAS 2501889-19-4 Whole-Virion Inactivated SARS-CoV-2 Vaccine UNII76JZE5DSN6 BBV 152 A whole virion inactivated COVID-19 vaccine candidate derived from SARS-CoV-2 strain NIV-2020-770 REF medRxiv (2020), 1-21. bioRxiv (2020), 1-32. BBV152 (also known as Covaxin) is an inactivated virus-based COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. BBV152 is a vaccine candidate created by the Indian …

AZD1222 (ChAdOx1), Oxford–AstraZeneca COVID-19 vaccine, COVISHIELD

It’s only fair to share… AZD1222 (ChAdOx1) Identifiers CAS Number 2420395-83-9 ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) COVISHIELD™ DNA (recombinant simian adenovirus Ox1 ΔE1E3 vector human cytomegalovirus promoter plus human tissue plasminogen activator signal peptide fusion protein with severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1 spike glycoprotein codon optimized-specifying) The University of Oxford, AstraZeneca …